AAAAAA

   
Results: 1-7 |
Results: 7
USE OF DEXAMETHASONE AND GRANISETRON IN THE CONTROL OF DELAYED EMESISFOR PATIENTS WHO RECEIVE HIGHLY EMETOGENIC CHEMOTHERAPY
Authors: LATREILLE J PATER J JOHNSTON D LABERGE F STEWART D RUSTHOVEN J HOSKINS P FINDLAY B MCMURTRIE E YELLE L WILLIAMS C WALDE D ERNST S DHALIWAL H WARR D SHEPHERD F MEE D NISHIMURA L OSOBA D ZEE B
Citation: J. Latreille et al., USE OF DEXAMETHASONE AND GRANISETRON IN THE CONTROL OF DELAYED EMESISFOR PATIENTS WHO RECEIVE HIGHLY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 16(3), 1998, pp. 1174-1178
THE EFFECT OF POSTTREATMENT MOBILITY ON REGENERATIVE HEALING IN FURCATIONS
Authors: DHALIWAL H GREENWELL H DRISKO C WITTWER J YANCEY J
Citation: H. Dhaliwal et al., THE EFFECT OF POSTTREATMENT MOBILITY ON REGENERATIVE HEALING IN FURCATIONS, Journal of dental research, 75, 1996, pp. 2468-2468
PREVENTING NAUSEA AND VOMITING DURING DAYS 2-7 FOLLOWING HIGH-DOSE CISPLATIN CHEMOTHERAPY (HDCP)
Authors: JOHNSTON D LATREILLE J LABERGE F STEWART D RUSTHOVEN J FINDLAY B ERNST S WILLIAMS CKO HOSKINS P YELLE L MCMURTRIE E DHALIWAL H NISHIMURA L PATER J ZEE B
Citation: D. Johnston et al., PREVENTING NAUSEA AND VOMITING DURING DAYS 2-7 FOLLOWING HIGH-DOSE CISPLATIN CHEMOTHERAPY (HDCP), European journal of cancer, 31A, 1995, pp. 1204-1204
DEXAMETHASONE IMPROVES THE EFFICACY OF GRANISETRON IN THE FIRST 24 H FOLLOWING HIGH-DOSE CISPLATIN CHEMOTHERAPY
Authors: LATREILLE J STEWART D LABERGE F HOSKINS P RUSTHOVEN J MCMURTRIE E WARR D YELLE L WALDE D SHEPHERD F DHALIWAL H FINDLAY B MEE D PATER J ZEE B JOHNSTON D
Citation: J. Latreille et al., DEXAMETHASONE IMPROVES THE EFFICACY OF GRANISETRON IN THE FIRST 24 H FOLLOWING HIGH-DOSE CISPLATIN CHEMOTHERAPY, Supportive care in cancer, 3(5), 1995, pp. 307-312
ANALGESIC EFFICACY AND SAFETY OF CONTROLLED-RELEASE CODEINE AND PLACEBO IN CANCER PAIN
Authors: BABUL N DHALIWAL H SLOAN P ARKINSTALL W THIRLWELL M HARSANYI Z DARKE A
Citation: N. Babul et al., ANALGESIC EFFICACY AND SAFETY OF CONTROLLED-RELEASE CODEINE AND PLACEBO IN CANCER PAIN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 137-137
STEADY-STATE DISPOSITION OF HYDROMORPHONE AND HYDROMORPHONE-3-GLUCURONIDE IN CANCER-PATIENTS
Authors: BABUL N HAGEN N THIRLWELL M DHALIWAL H HARSANYI Z DARKE A
Citation: N. Babul et al., STEADY-STATE DISPOSITION OF HYDROMORPHONE AND HYDROMORPHONE-3-GLUCURONIDE IN CANCER-PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 165-165
COMPARATIVE CLINICAL EFFICACY AND SAFETY OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE HYDROMORPHONE FOR CHRONIC SEVERE CANCER PAIN
Authors: HAYS H HAGEN N THIRLWELL M DHALIWAL H BABUL N HARSANYI Z DARKE AC
Citation: H. Hays et al., COMPARATIVE CLINICAL EFFICACY AND SAFETY OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE HYDROMORPHONE FOR CHRONIC SEVERE CANCER PAIN, Cancer, 74(6), 1994, pp. 1808-1816
Risultati: 1-7 |